Coverage Initiated On GW Pharmaceuticals By: MarketMinute.com Stock News April 22, 2014 at 13:56 PM EDT Morgan Stanley initiated coverage of GW Pharmaceuticals (Nasdaq: GWPH) with an Overweight rating and a price target of $103 sending the stock price soaring $15.88 to $61.92. Related Stocks: Gw Pharma ADR